IMPACT OF COMPLICATIONS IN SOLID ORGAN TRANSPLANTS ON HOSPITAL CHARGES AND LENGTH OF STAY

Author(s)

Jensen IS, Helm T, Cyr PLNavigant, Inc., Boston, MA, USA

OBJECTIVES: Solid organ transplants (SOT) are expensive, and much of the cost is incurred in the first 3 months of care to cover pre-transplant, procurement and procedural costs, which can reach >$200,000 per transplant, and higher with complications. Delayed graft function (DGF) is a complication affecting 20-40% of kidney transplants and is believed to result from ischemic reperfusion injury (IRI).  The objective of this analysis is to quantify the additional charges and length of stay (LOS) associated with complications such as DGF.  METHODS: Using 2008 Health Care Utilization Project (HCUP) data, individuals with a recorded transplant procedure (ICD-9 CM: 07.94 (thymus); 33.50-33.52 (lung); 336 (heart-lung); 41.94 (spleen); 46.97 (intestine); 50.51 and 50.59 (liver); 52.80-52.83 (pancreas); 65.92 (ovary) were identified. The mean hospital charges for individuals with and without a recorded complication diagnosis (ICD-9 CM 996.80-996.89 and additionally for kidney patients a recorded dialysis procedure 39.95) were compared using student’s t-test.   RESULTS:  The number of SOTs (and complications) for each organ type were: 4119 (21%) kidney, 1677 (17%) liver, 485 (28%) heart, and 264 (35%) lung. Heart-lung, intestine, pancreas and spleen were excluded from the analysis with <100 transplants each. Kidney and liver transplant patients with complications had significantly higher mean hospital charges and LOS than those without the complications: kidney ($209,503 vs. $160,997, p<0.001) and (7.0 days vs. 11.1 days, p<0.001), and liver ($460,351 vs. $340,296, p<0.001) and (21.0 days vs. 31.6 days). Heart and Lung transplant patients had higher charges than those without the complication diagnosis. The difference was not statistically significant.  CONCLUSIONS:  Our results demonstrate that having to treat complications of transplants adds significantly to the cost of hospital care and LOS.  There is a need for a novel agent that may reduce IRI.  Proactive management of patients with risk of IRI may confer substantial savings to hospitals.

Conference/Value in Health Info

2012-06, ISPOR 2012, Washington, D.C., USA

Value in Health, Vol. 15, No. 4 (June 2012)

Code

PSU15

Topic

Economic Evaluation

Topic Subcategory

Cost/Cost of Illness/Resource Use Studies

Disease

Systemic Disorders/Conditions, Urinary/Kidney Disorders

Explore Related HEOR by Topic


Your browser is out-of-date

ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now

×